Clinical trials
10 active studies led by C. R. Bard, of 117 in all
Source: ClinicalTrials.gov, Studies with C. R. Bard (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show C. R. Bard in 2 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by C. R. Bard or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
10 active studies led by C. R. Bard, of 117 in all
Source: ClinicalTrials.gov, Studies with C. R. Bard (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
94 510(k) clearances and PMA approvals since 2015
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
122 recalls since 2015 (122 for devices)
Source: openFDA, FDA enforcement reports (recalls) naming the firm, since 2015. Retrieved 13 Nov 2026.
Studies C. R. Bard leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with C. R. Bard or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show C. R. Bard: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets C. R. Bard is in.
Stories on the topics C. R. Bard works in.
WHO says only about half of patients in developed countries take long-term medicines as prescribed. Patient…
Read
More than 300 million operations are done each year, and many no longer need an overnight stay. Ambulatory…
Read
More than 300 million operations are performed each year. Energy-based devices that cut and seal tissue with…
Read